PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34911496-3	2021	Cancer de-differentiation transforms luminal-like (differentiated) adenocarcinoma into less luminal-like and more stem-like (undifferentiated) small cell carcinoma through a sequential activation of stem cell transcription factors (scTF) POU5F1, LIN28A, SOX2 and NANOG.	Phenobarbital	37-44	SRY-box transcription factor 2	Homo sapiens	254-258	
29417440-5	2018	Phenobarbital also reduced expression of neuronal markers (doublecortin (DCX), calretinin, NeuN), neuronal transcription factors (Pax6, Sox2, Tbr1/2, Prox1), and neurotrophins (NGF, BDNF, NT-3) up to 24 h after the last administration.	Phenobarbital	0-13	SRY-box transcription factor 2	Homo sapiens	136-140	
32191225-5	2020	Using high-throughput transcriptional data available from the METABRIC dataset, high expression of SOX2 was significantly more common in luminal-B and HER2-enriched subtypes according to PAM50 classifier and in IntClust1 (high proliferating luminal-B) and IntClust 5 (luminal-B and HER2-amplified) according to integrative clustering.	Phenobarbital	137-144	SRY-box transcription factor 2	Homo sapiens	99-103	
32191225-5	2020	Using high-throughput transcriptional data available from the METABRIC dataset, high expression of SOX2 was significantly more common in luminal-B and HER2-enriched subtypes according to PAM50 classifier and in IntClust1 (high proliferating luminal-B) and IntClust 5 (luminal-B and HER2-amplified) according to integrative clustering.	Phenobarbital	241-248	SRY-box transcription factor 2	Homo sapiens	99-103	
32191225-7	2020	Iadademstat reduced the expression of SOX2 in luminal-B but not in luminal-A mammospheres, likely indicating a selective targeting of SOX2-driven CSC.	Phenobarbital	46-53	SRY-box transcription factor 2	Homo sapiens	38-42